GlaxoSmithKline Statement Lancet Publication Of D:A:D Data

Data published in the Lancet from the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) suggest a possible association between anti-retroviral therapy (ART) regimens that contain abacavir and an increased risk of myocardial infarction. Conversely, analyses of GlaxoSmithKline data show no increased risk of myocardial infarction associated with abacavir.

More: continued here

Filed under: Cardiovascular on April 6th, 2008